オハイオにおける頭頸部扁平上皮癌の臨床試験
オハイオ内の拠点で、頭頸部扁平上皮癌に関する46件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Aultman Health Foundation, Canton
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06992427FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site#0154, Canton
- Site#0117, Cincinnati
- Site #0151, Cleveland
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06788990A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #10, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Miami Valley Hospital South, Centerville
- Miami Valley Hospital, Dayton
- Miami Valley Hospital North, Dayton
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06589804A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 10, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Site 06, Maumee
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07814248BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Miami Valley Hospital South, Centerville
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- University of Cincinnati, Cincinnati
- Ohio State University, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07276399JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- University of Cincinnati, Cincinnati
被験者募集中第3相
60歳以上 · 全性別 · 2026/09/25更新 · NCT04892173Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06980038A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Cleveland Clinic, Cleveland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06385080Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Miami Valley Hospital South, Centerville
- Cleveland Clinic Foundation, Cleveland
- Premier Blood and Cancer Center, Dayton
- 他3件
被験者募集中第2相
18歳〜79歳 · 全性別 · 2026/09/22更新 · NCT04671667A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- UH Cleveland Medical Center, Cleveland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- Indu and Raj Soin Medical Center, Beavercreek
- Saint Elizabeth Boardman Hospital, Boardman
- 他22件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cleveland Clinic, Cleveland
- Toledo Clinic Cancer Center, Toledo
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06535607First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06657222A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- University of Cincinnati, Cincinnati
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/03更新 · NCT06163534A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Ohio State University, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06769698A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Maumee
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Summa Health System - Akron Campus, Akron
- Aultman Health Foundation, Canton
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- ProMedica Flower Hospital, Sylvania
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07441681Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- The Ohio State University, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/13更新 · NCT05985655SMP-3124LP in Adults With Advanced Solid Tumors
- Ohio State University, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06526819Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT06627270A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
- Taylor Cancer Research Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/24更新 · NCT04754321A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05208762First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- UH Cleveland Medical Center, Cleveland
- Stefanie Spielman Comprehensive Breast Center, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
- University of Cincinnati Medical Center, Cincinnati
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/01更新 · NCT07213934A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Canton
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/26更新 · NCT06256588Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
- University of Cincinnati Medical Center, Cincinnati
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/18更新 · NCT07497607A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
- The Cleveland Clinic Foundation, Cleveland
被験者募集中第2/3相
18歳〜100歳 · 全性別 · 2026/04/23更新 · NCT05893888A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/06更新 · NCT05785741Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/03/24更新 · NCT06323460Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Cleveland Clinic, Cleveland
- Taylor Cancer Research Center, Maumee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- Ohio State University Medical Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/02/10更新 · NCT01473784ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。